Funding for this research was provided by:
Uppsala University
Article History
Received: 27 August 2020
Revised: 16 December 2020
Accepted: 21 December 2020
First Online: 7 January 2021
Compliance with ethical standards
:
: Author E Granstam is an advisory board member for Novartis, Bayer and Allergan and has received speaker honorarium from these companies. Author K Sjövall is an advisory board member for Novartis, Bayer and Allergan. Authors S Aurell and A Paul declare that they have no conflicts of interest.
: The study was approved by the regional ethics committee of Uppsala/Örebro (Dnr 2018/521, approval date December 12, 2018) and adhered to the tenets of the 1964 Declaration of Helsinki and its later amendments. Each patient approved the registration of medical data in the Swedish Macular Register (SMR) and additional consent for participation in the present study was not required as by the approval by the regional ethics committee.